Tiziana Life Sciences (TILS) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Dosing begins in Tiziana Life Sciences’ trial of foralumab for na-SPMSApril 24, 2025 | msn.comTiziana Life Sciences (TLSA) Expands Clinical Trial for MS Treatment | TLSA Stock NewsApril 23, 2025 | gurufocus.comTiziana Life Sciences Expands Phase 2 Trial for Intranasal Foralumab with UMass DosingApril 23, 2025 | tipranks.comTiziana Life Sciences Expands Phase 2 Trial for Multiple Sclerosis TreatmentApril 2, 2025 | tipranks.comTiziana Life Sciences files $250M mixed securities shelfMarch 27, 2025 | markets.businessinsider.comTiziana Life Sciences begins dosing in trial of therapy for multiple sclerosisMarch 27, 2025 | msn.comTiziana Life Sciences announces dosing of new patients at Yale MS CenterMarch 26, 2025 | markets.businessinsider.comTiziana Life Sciences CEO to Present at ROTH ConferenceMarch 17, 2025 | tipranks.comTiziana Life Sciences regains compliance with Nasdaq listing ruleMarch 14, 2025 | markets.businessinsider.comTiziana Life Sciences Regains Nasdaq Compliance, Secures Continued ListingMarch 14, 2025 | tipranks.comTiziana Life Sciences regains Nasdaq complianceMarch 14, 2025 | seekingalpha.comTiziana Life Sciences files IND application with FDA for ALS Phase 2 trialMarch 4, 2025 | markets.businessinsider.comTiziana Life Sciences ticks up on IND submission for mid-stage trial of its ALS treatmentMarch 4, 2025 | msn.comTiziana Life Sciences Advances ALS Treatment with FDA IND SubmissionMarch 4, 2025 | tipranks.comTiziana Life Sciences’ nasal therapy shows efficacy in traumatic brain injuryFebruary 27, 2025 | markets.businessinsider.comTiziana stock jumps 12% on TBI drug study publicationFebruary 27, 2025 | msn.comTiziana Life Sciences Unveils Promising Nasal Therapy for Traumatic Brain InjuryFebruary 27, 2025 | tipranks.comTiziana Life Sciences Nears Completion of Promising Long COVID Treatment StudyFebruary 25, 2025 | tipranks.comTiziana enters product development services agreement with RenaissanceFebruary 21, 2025 | markets.businessinsider.comTiziana Life Sciences Partners with Renaissance for Nasal Drug Scale-UpFebruary 21, 2025 | tipranks.comTiziana Life Sciences enters product development services pact with Renaissance LakewoodFebruary 21, 2025 | seekingalpha.comTiziana Life Sciences Expands Access to Multiple Sclerosis TreatmentFebruary 18, 2025 | tipranks.comTiziana Life Sciences Highlights Foralumab’s Potential in Alzheimer’s TreatmentFebruary 11, 2025 | tipranks.comTiziana Life Sciences Faces Nasdaq Compliance ChallengeJanuary 31, 2025 | tipranks.comTiziana Life Sciences Reports Breakthrough in Spinal Cord Injury TreatmentJanuary 24, 2025 | tipranks.comTiziana Life Sciences Shares Higher on Positive Results for Spinal Cord Injury TreatmentJanuary 23, 2025 | marketwatch.comTiziana reports progress in spinal cord injury treatmentJanuary 23, 2025 | msn.comNeurology-Focused Tiziana Life Confirms Discovery In Multiple Sclerosis Therapy StudyJanuary 23, 2025 | benzinga.comTiziana Life Sciences announces discovery of new immune biomarkersJanuary 23, 2025 | markets.businessinsider.comTiziana’s Nasal Therapy Reduces GLP-1 Side EffectsJanuary 10, 2025 | tipranks.comTiziana Life Sciences announces review article on foralumab’s potentialJanuary 9, 2025 | markets.businessinsider.comTiziana Life Sciences’ Foralumab Shows Promise in Neurodegenerative Disease TreatmentJanuary 9, 2025 | markets.businessinsider.comTiziana Life Sciences announces first patient dosed with intranasal foralumabDecember 17, 2024 | tipranks.comTiziana Life Sciences Expands MS Clinical Trial NetworkDecember 5, 2024 | markets.businessinsider.comTiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS AssociationNovember 19, 2024 | markets.businessinsider.comTiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination StudyNovember 1, 2024 | finanznachrichten.deTiziana Life Sciences Plans Share Sale with JefferiesOctober 26, 2024 | markets.businessinsider.comTiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s DiseaseSeptember 20, 2024 | markets.businessinsider.comTiziana Life Appoints Ivor Elrifi As CEOAugust 19, 2024 | markets.businessinsider.comTiziana Life Sciences Appoints Ivor Elrifi as CEOAugust 19, 2024 | marketwatch.comTiziana Life Sciences Ltd.: Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price RuleAugust 16, 2024 | finanznachrichten.deTiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price RuleAugust 14, 2024 | markets.businessinsider.comTiziana spikes on FDA fast track tag for lead assetJuly 24, 2024 | msn.comTiziana Life Sciences to present immunotherapy updates at...Tiziana Life Sciences to present immunotherapy updates at Webull...December 6, 2023 | proactiveinvestors.comTiziana : FDA Allows Multiple Sclerosis Patients To Take Home & Self-administer Intranasal ForalumabOctober 18, 2023 | markets.businessinsider.comTiziana Life Sciences: FDA signs off on home-based protocol fo MS treatmentOctober 18, 2023 | proactiveinvestors.comTiziana Life Sciences Announces Positive Six-Month Clinical Results in Multiple Sclerosis Patients Treated with Intranasal ForalumabOctober 16, 2023 | markets.businessinsider.comTiziana Life Sciences reports six-month PET scan results for MS patientsOctober 13, 2023 | proactiveinvestors.comTiziana Life Sciences Ltd (0RP)September 26, 2023 | uk.investing.comTiziana Life Sciences Initiates Multi-Center Phase 2a Clinical Trial of Intranasal Foralumab for Non-Active Secondary Progressive Multiple SclerosisSeptember 26, 2023 | tmcnet.com Get Tiziana Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TILS and its competitors with MarketBeat's FREE daily newsletter. Email Address TILS Media Mentions By Week TILS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TILS News Sentiment▼0.000.83▲Average Medical News Sentiment TILS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TILS Articles This Week▼01▲TILS Articles Average Week Get Tiziana Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TILS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PRTC News Today OXB News Today FARN News Today 4BB News Today BVXP News Today AVCT News Today HVO News Today SCLP News Today OBI News Today SBTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:TILS) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredReal Americans Don’t Wait on Wall Street’s Next MoveWhat's happening in the markets right now should concern every freedom-loving American who's worked hard and s...Premier Gold Co | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tiziana Life Sciences PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Tiziana Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TILS Stock Free TILS Stock Alerts